ORCID as entered in ROS

Select Publications
2025, 'Readiness and leadership for the implementation of polygenic risk scores: Genetic healthcare providers' perspectives in the hereditary cancer context', Journal of Genetic Counseling, 34, http://dx.doi.org/10.1002/jgc4.70084
,2025, 'Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer', Clinical and Translational Science, 18, http://dx.doi.org/10.1111/cts.70323
,2025, 'Defining next steps in the clinical implementation of polygenic scores: A landscape analysis of professional groups’ perspectives', Genetics in Medicine, 27, http://dx.doi.org/10.1016/j.gim.2025.101414
,2025, 'Genetic counsellors: facilitating the integration of genomics into health care', Medical Journal of Australia, 222, pp. 114 - 117, http://dx.doi.org/10.5694/mja2.52568
,2025, 'Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2', Journal of Clinical Oncology, 43, pp. 422 - 431, http://dx.doi.org/10.1200/JCO.24.00176
,2025, 'Considering Clinical Implementation of Polygenic Scores in Hereditary Cancer Risk Assessment: Recipients’ Perspectives on Influencing Factors and Strategies', Patient, http://dx.doi.org/10.1007/s40271-025-00747-5
,2025, 'Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer', European Journal of Human Genetics, 33, pp. 108 - 120, http://dx.doi.org/10.1038/s41431-024-01729-1
,2024, 'Systematic review of the uptake and outcomes from returning secondary findings to adult participants in research genomic testing', Journal of Genetic Counseling, 33, pp. 1145 - 1158, http://dx.doi.org/10.1002/jgc4.1865
,2024, 'Using polygenic risk modification to improve breast cancer prevention: Study protocol for the PRiMo multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2024-087874
,2024, 'Publics’ knowledge of, attitude to and motivation towards health-related genomics: a scoping review', European Journal of Human Genetics, 32, pp. 747 - 758, http://dx.doi.org/10.1038/s41431-024-01547-5
,2024, 'Navigating genomic testing: Evaluation of an e-learning module with general practitioners', FOCUS ON HEALTH PROFESSIONAL EDUCATION-A MULTIDISCIPLINARY JOURNAL, 25, pp. 37 - 50
,2023, 'Development and evaluation of a novel educational program for providers on the use of polygenic risk scores', Genetics in Medicine, 25, http://dx.doi.org/10.1016/j.gim.2023.100876
,2023, 'Human Genetics Society of Australasia Position Statement: Use of Polygenic Scores in Clinical Practice and Population Health', Twin Research and Human Genetics, 26, pp. 40 - 48, http://dx.doi.org/10.1017/thg.2023.10
,2023, 'Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: A systematic review', Genetics in Medicine, 25, pp. 1 - 11, http://dx.doi.org/10.1016/j.gim.2022.09.008
,2022, 'Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanoma', Frontiers in Genetics, 13, http://dx.doi.org/10.3389/fgene.2022.919134
,2022, 'Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals', Internal Medicine Journal, 52, pp. 1135 - 1143, http://dx.doi.org/10.1111/imj.15719
,2022, 'The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study', Journal of Personalized Medicine, 12, http://dx.doi.org/10.3390/jpm12071112
,2022, 'TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members', Journal of Clinical Oncology, 40, pp. 2036 - 2047, http://dx.doi.org/10.1200/JCO.21.02108
,2022, 'Population DNA screening for medically actionable disease risk in adults', Medical Journal of Australia, 216, pp. 278 - 280, http://dx.doi.org/10.5694/mja2.51454
,2022, 'My Research Results: a program to facilitate return of clinically actionable genomic research findings', European Journal of Human Genetics, 30, pp. 363 - 366, http://dx.doi.org/10.1038/s41431-021-00973-z
,2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics Part A, 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563
,2022, 'Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk', Journal of Genetic Counseling, 31, pp. 120 - 129, http://dx.doi.org/10.1002/jgc4.1458
,2021, 'Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior', Genetics in Medicine, 23, pp. 2316 - 2323, http://dx.doi.org/10.1038/s41436-021-01288-6
,2021, 'Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice', Hereditary Cancer in Clinical Practice, 19, http://dx.doi.org/10.1186/s13053-021-00180-3
,2021, 'Unselected Women's Experiences of Receiving Genetic Research Results for Hereditary Breast and Ovarian Cancer: A Qualitative Study', Genetic Testing and Molecular Biomarkers, 25, pp. 741 - 748, http://dx.doi.org/10.1089/gtmb.2021.0115
,2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho Oncology, 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764
,2021, 'Communicating polygenic risk scores in the familial breast cancer clinic', Patient Education and Counseling, 104, pp. 2512 - 2521, http://dx.doi.org/10.1016/j.pec.2021.02.046
,2021, 'Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross-sectional survey of health professionals', Clinical Genetics, 100, pp. 430 - 439, http://dx.doi.org/10.1111/cge.14025
,2021, 'Supporting teachers to use genomics as a context in the classroom: an evaluation of learning resources for high school biology', Journal of Community Genetics, 12, pp. 653 - 662, http://dx.doi.org/10.1007/s12687-021-00550-3
,2021, 'Education in youth-friendly genetic counseling', Journal of Genetic Counseling, 30, pp. 1133 - 1142, http://dx.doi.org/10.1002/jgc4.1397
,2021, 'Oncologists’ perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer', Journal of Community Genetics, 12, pp. 449 - 457, http://dx.doi.org/10.1007/s12687-021-00530-7
,2021, 'Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: ‘Another piece of the pie’', Journal of Genetic Counseling, 30, pp. 849 - 860, http://dx.doi.org/10.1002/jgc4.1384
,2021, 'Professional regulation for Australasian genetic counselors', Journal of Genetic Counseling, 30, pp. 361 - 369, http://dx.doi.org/10.1002/jgc4.1344
,2021, 'Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk', Psycho Oncology, 30, pp. 159 - 166, http://dx.doi.org/10.1002/pon.5556
,2021, 'Social media usage in family communication about genetic information: ‘I no longer speak with my sister but she needed to know’', Journal of Genetic Counseling, 30, pp. 180 - 190, http://dx.doi.org/10.1002/jgc4.1307
,2020, 'Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics', Familial Cancer, 19, pp. 337 - 346, http://dx.doi.org/10.1007/s10689-020-00183-4
,2020, 'Women’s responses and understanding of polygenic breast cancer risk information', Familial Cancer, 19, pp. 297 - 306, http://dx.doi.org/10.1007/s10689-020-00185-2
,2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', Journal of Clinical Oncology, 38, pp. 1541 - 1541, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1541
,2020, 'A framework for youth-friendly genetic counseling', Journal of Community Genetics, 11, pp. 161 - 170, http://dx.doi.org/10.1007/s12687-019-00439-2
,2020, 'Uptake of polygenic risk information among women at increased risk of breast cancer', Clinical Genetics, 97, pp. 492 - 501, http://dx.doi.org/10.1111/cge.13687
,2020, 'Clinical applications of polygenic breast cancer risk: A critical review and perspectives of an emerging field', Breast Cancer Research, 22, pp. 21, http://dx.doi.org/10.1186/s13058-020-01260-3
,2020, 'Who should access germline genome sequencing? A mixed methods study of patient views', Clinical Genetics, 97, pp. 329 - 337, http://dx.doi.org/10.1111/cge.13664
,2020, 'Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes', Nature Genetics, 52, pp. 56 - 73, http://dx.doi.org/10.1038/s41588-019-0537-1
,2019, 'Homologous recombination DNA repair defects in PALB2-associated breast cancers', Npj Breast Cancer, 5, http://dx.doi.org/10.1038/s41523-019-0115-9
,2019, 'Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)', Npj Breast Cancer, 5, http://dx.doi.org/10.1038/s41523-019-0140-8
,2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports, 9, pp. 17052, http://dx.doi.org/10.1038/s41598-019-52000-3
,2019, 'Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer', European Journal of Human Genetics, 27, pp. 1186 - 1196, http://dx.doi.org/10.1038/s41431-019-0390-9
,2019, 'Patient perspectives on molecular tumor profiling: "why wouldn't you?"', BMC Cancer, 19, pp. 753, http://dx.doi.org/10.1186/s12885-019-5920-x
,2019, 'High-risk women’s risk perception after receiving personalized polygenic breast cancer risk information', Journal of Community Genetics, 10, pp. 197 - 206, http://dx.doi.org/10.1007/s12687-018-0378-0
,2019, 'Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility', Genetics in Medicine, 21, pp. 913 - 922, http://dx.doi.org/10.1038/s41436-018-0277-0
,